|
Arteris, Inc.
Condensed Consolidated Balance Sheets (In thousands, except share and per share data) | |||||||
| As of December 31, | |||||||
| 2023 | 2022 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 13,696 | $ | 37,423 | |||
| Short-term investments | 27,477 | 30,728 | |||||
| Accounts receivable, net of allowance of $93 and $250 as of December 31, 2023 and 2022, respectively | 12,003 | 7,143 | |||||
| Prepaid expenses and other current assets | 5,254 | 5,818 | |||||
| Total current assets | 58,430 | 81,112 | |||||
| Property and equipment, net | 5,745 | 3,617 | |||||
| Long-term investments | 11,802 | 4,427 | |||||
| Equity method investment | 8,500 | 11,897 | |||||
| Operating lease right-of-use assets | 4,289 | 1,883 | |||||
| Intangibles, net | 3,858 | 4,575 | |||||
| Goodwill | 4,178 | 4,218 | |||||
| Other assets | 5,999 | 3,787 | |||||
| TOTAL ASSETS | $ | 102,801 | $ | 115,516 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 183 | $ | 572 | |||
| Accrued expenses and other current liabilities | 11,831 | 12,095 | |||||
| Operating lease liabilities, current | 781 | 899 | |||||
| Deferred revenue, current | 31,537 | 28,839 | |||||
| Vendor financing arrangements, current | 2,070 | 1,264 | |||||
| Total current liabilities | 46,402 | 43,669 | |||||
| Deferred revenue, noncurrent | 25,172 | 21,840 | |||||
| Operating lease liabilities, noncurrent | 3,610 | 1,009 | |||||
| Vendor financing arrangements, noncurrent | 1,292 | 448 | |||||
| Deferred income, noncurrent | 8,810 | 9,993 | |||||
| Other liabilities | 2,412 | 1,022 | |||||
| Total liabilities | 87,698 | 77,981 | |||||
| Commitments and contingencies | |||||||
| Stockholders’ equity: | |||||||
| Preferred stock, par value of $0.001—10,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2023 and 2022 | — | — | |||||
| Common stock, par value of $0.001—300,000,000 shares authorized at December 31, 2023 and 2022; 37,518,583 and 34,625,875 shares issued and outstanding at December 31, 2023 and 2022, respectively | 37 | 34 | |||||
| Additional paid-in capital | 118,193 | 103,778 | |||||
| Accumulated other comprehensive income | 120 | 101 | |||||
| Accumulated deficit | (103,247 | ) | (66,378 | ) | |||
| Total stockholders’ equity | 15,103 | 37,535 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 102,801 | $ | 115,516 | |||
